Sort
82,697 grants matching “vaccine development”
Development of a COVID Vaccine Model in NHP
$845,146Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Ion Channel Assay for Identifying Influenza Therapeutics
$845,142Benjamin Jacob Doranz · Integral Molecular · R01 · FY2006 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$845,133Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2025 · AI
Structure-based design of coronavirus subunit vaccines
$845,133Lanying Du · New York Blood Center · R01 · FY2019 · AI
Host Immune Responses to Antigens of Malaria Parasites
$845,075Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$845,032Kathleen Powis · Massachusetts General Hospital · R01 · FY2023 · AI
NIH Director's Pioneer Award
$845,000Evgeny Nudler · New York University School Of Medicine · DP1 · FY2006 · OD
NIH Director's Pioneer Award
$845,000Evgeny Nudler · New York University School Of Medicine · DP1 · FY2007 · OD
Development of the Next Generation of Conjugate Vaccines
$844,945Luc Teyton · Scripps Research Institute, The · R01 · FY2020 · AI
BIOMEDICAL RESEARCH INFRASTRUCTURE AT ALABAMA STATE UNI*
$844,926Kennedy S Wekesa · Alabama State University · P20 · FY2007 · MD
Host control in Coccidioidomycosis
$844,908University Of Arizona · P01 · FY2004 · AI
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
$844,900Lanying Du · New York Blood Center · R01 · FY2018 · AI
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,866Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MH
Development of an oral liver-targeted prime-and-trap malaria vaccine
$844,865Sean C Murphy · University Of Washington · U01 · FY2022 · AI
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,801Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · MH
Cerebrospinal fluid (CSF) and peripheral markers of the neuropsychiatric sequelae of COVID-19: The Generation C-SF pregnancy study
$844,677Maria De Las Mercedes Perez Rodriguez · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Development of a pre-erythrocytic P. vivax vaccine to prevent clinical relapse
$844,617D. Noah Sather · Seattle Children'S Hospital · R01 · FY2019 · AI
Food & Waterborne Diseases Integrated Research Network
$844,557Yrjo Grohn · Cornell University · N01 · FY2009 · AI
Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine
$844,491Afamefuna Okoye · Oregon Health & Science University · R01 · FY2021 · AI
Discovery and development of broad spectrum anti-flaviviral drugs
$844,425Mariano A. Garcia-Blanco · Duke University · R01 · FY2011 · AI
The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors
$844,362Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
$844,320Erol Fikrig · Yale University · R01 · FY2021 · AI
Development of Viral Vaccines against Sarbecoviruses and Merbecoviruses
$844,055Michael S. Diamond · Washington University · P01 · FY2025 · AI
Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection
$844,040Ada S Cowan · Metallopharm, Llc · R44 · FY2011 · AA
Elucidating the role of TSR glycosylation in Plasmodium parasites
$844,019Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2022 · AI